HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Craniopharyngioma

Craniopharyngioma

Craniopharyngioma is a rare type of brain tumor, typically benign, but challenging to treat due to its location near critical structures in the brain. Research in cancer treatment for craniopharyngioma focuses on innovative approaches to mitigate side effects and improve outcomes. Novel therapies such as targeted drug delivery systems and immunotherapy are being explored to minimize damage to surrounding tissues while effectively targeting tumor cells. Additionally, advancements in imaging techniques aid in precise tumor localization for surgical removal, reducing the risk of recurrence. Collaborative efforts between clinicians, researchers, and pharmaceutical companies aim to develop personalized treatment strategies tailored to the specific genetic and molecular characteristics of each patient's tumor, offering hope for improved prognosis and quality of life.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp